Intensive nutrition support may benefit patients with a rare mitochondrial disorder

Nutr Clin Pract. 2022 Apr;37(2):361-365. doi: 10.1002/ncp.10726. Epub 2021 Jun 25.

Abstract

Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare, inherited, multisystemic autosomal recessive disorder caused by mutations in the nuclear TYMP gene. This syndrome is characterized by ptosis, external ophthalmoplegia, gastrointestinal dysmotility, cachexia, peripheral neuropathy, and leukoencephalopathy. Our case illustrates a patient diagnosed with MNGIE and cachexia who has benefited from the initiation and maintenance of parenteral nutrition. We highlight the benefits of receiving long-term supplementary home parenteral nutrition under close monitoring for patients with this neurogastrointestinal disease in order to gain weight and maintain good health.

Keywords: cachexia; encephalopathy; gastrointestinal disease; mitochondrial encephalomyopathies; parenteral nutrition.

MeSH terms

  • Humans
  • Intestinal Pseudo-Obstruction* / genetics
  • Intestinal Pseudo-Obstruction* / therapy
  • Mitochondrial Diseases* / complications
  • Mitochondrial Diseases* / genetics
  • Mitochondrial Diseases* / therapy
  • Mitochondrial Encephalomyopathies* / diagnosis
  • Mitochondrial Encephalomyopathies* / genetics
  • Muscular Dystrophy, Oculopharyngeal*
  • Ophthalmoplegia*